NEW YORK, Feb. 9 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. , a medical technology company testing its proprietary treatment system for primary and metastatic ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback